Browsing byAuthor문영철

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 139 to 168 of 186

Issue DateTitleAuthor(s)Type
2009Reactive Oxygen Species Might Have Important Roles On Angiogenesis of Endothelial Progenitor Cells Derived From HCB(Human Cord Blood) Which Are Stimulated by VEGF.성주명; 유은선; 이경은; 문영철; 남은미Meeting Abstract
2023Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation문영철Article
2022Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology문영철Article
2011Reduced-intensity conditioning allogeneic stem cell transplantation in the patients with acute leukemia김현경Master's Thesis
2020Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia문영철Article
2022Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma문영철Article
2007Restoration of peroxiredoxins and catalase is closely correlated with the level of Philadelphia chromosome during imatinib therapy in CML성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 우현애Meeting Abstract
2013RESTORATION OF REDOX ENZYMES IS CORRELATED WITH REDUCTION OF BCR-ABL PROTEIN IN PHILADELPHIA POSITIVE CELLS DURING IMATINIB THERAPY성주명; 유은선; 허정원; 문영철Meeting Abstract
2012Ring Chromosome 5 in acute myeloid leukemia defned by whole-genome single nucleotide polymorphism array정화순; 성주명; 허정원; 문영철Article
2021Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis문영철Article
2008Risk factors of radiation pneumonitis in lung cancer성주명; 이경은; 문영철Meeting Abstract
2018Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma문영철Article
2012Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.문영철Meeting Abstract
2011Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis문영철Meeting Abstract
2022Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study문영철; 김선종; 김진우; 정태동; 박정현Article
2005Signaling mechanisms of anti-proliferation by sphingosine 1-phoshate (S1P) on acute promyelocytic leukaemia cell lines성주명; 문영철Meeting Abstract
2013Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality정화순; 성주명; 허정원; 문영철Article
2011Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML정화순; 성주명; 허정원; 문영철Article
2019Somatic mutation of HLA-DRB1*04:03 in a patient with myelodysplastic syndrome at diagnosis허정원; 문영철; 정태동; 박설희Article
2015Submicroscopic Deletions of Immunoglobulin Heavy Chain Gene (IGH) in Precursor B Lymphoblastic Leukemia with IGH Rearrangements정화순; 성주명; 유은선; 허정원; 문영철Article
2014Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea.문영철Article
2022Suppressive effect of α-mangostin for cancer stem cells in colorectal cancer via the Notch pathway정성애; 문영철; 김성은; 문창모; 김민석; 안영호Article
2021The 2020 revision of the guidelines for the management of myeloproliferative neoplasms문영철Review
2016The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea문영철Article
2007The clinical outcomes of autologous stem cell transplantation in peripheral T cell lymphoma: From retrospective Multicenter study in Korea.문영철Meeting Abstract
2018The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma문영철Article
2020The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)문영철Article
2007The equal activity of azacytidine in 4 risk groups of IPSS in MDS문영철Meeting Abstract
2006The intention to treat analysis of the different post remission therapy modalities in AML patients with the "Intermediate Risk Group (IPG)" based on cytogenetics.성주명; 문영철Meeting Abstract
2007The intention to treat analysis of the different post-remission therapy modalities in AML patients with the Intermediate Risk Group based on cytogenetics문영철Meeting Abstract

BROWSE